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130a Sunday, February 8, 2015Mammalian sperm motility and fertility potential are regulated by ion ho-
meostasis which is controlled by a suite of ion permeable channels and trans-
porters working in concert. While all mammalian sperm share in their goal to
navigate the female reproductive tract in search of an egg, the molecular
regulation of this process is extremely diverse and differs dramatically
among species. Here we report that electrophysiological recordings from
sperm cells of different species illustrate marked differences between rodent,
human and ruminant sperm on the basis of their ion channel make-up and
regulation. Furthermore, localization patterning of ion channels along the
length of sperm flagella show species specific configuration. It is from these
observed differences that we can now begin to explain the disparity in
motility parameters among species as well as determine the effect proper
spatiotemporal regulation of ion concentrations have on proper sperm
motility.Cardiac Muscle Regulation I
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Cardiac troponin (cTn) is composed of troponins C, I, and T. cTnC is the
Ca2þ-dependent switch for cardiac muscle contraction. A decrease in calcium
activation, and a subsequent decrease in cardiac contractility, has been linked
to cardiac diseases such as familial hypertrophic cardiomyopathy. Calcium
sensitizers targeting cTn are a promising pharmacological approach to stimu-
lating contractility through increased sensitization or stabilization of Ca2þ-
induced changes. We developed an in vitro assay to measure the actions of
Ca2þ sensitizers on cTn within reconstituted regulated actin (rAc) (cTn, tropo-
myosin, f-actin). The assay utilizes fluorescence resonance energy transfer
(FRET) to monitor structural changes of troponin as a function of pCa. A
donor and acceptor fluorophore were covalently attached to the mobile
domain of cTnI and the C-lobe of cTnC, respectively. The fluorophore posi-
tions were selected due to the large observed Ca2þ-induced distance change
(1.8 nm), allowing for an assay highly sensitive to pCa fluctuations and
Ca2þ-sensitizing effects. Steady-state calcium titrations were performed to
monitor fluctuations in Ca2þ affinity in the presence of two Ca2þ sensitizers
known to bind to cTnC: Levosimendan and bepridil. Bepridil was shown to
increase Ca2þ sensitivity, while Levosimendan was shown to have little effect
on Ca2þ sensitivity. Additionally, bepridil appeared to prevent troponin from
closing under Ca2þ-saturating conditions, a structural effect that may give
insight into the mechanism of Ca2þ sensitization of cTn. This assay is a
fast approach to monitor the effects of Ca2þ sensitizers on cTn within the
thin filament.
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We reconstituted regulated actin filaments from troponin bearing one of 36
unique FRET reporter assays. Each FRET assay contained a donor dye
attached to a residue within the C-terminal domain of mouse cardiac troponin
I (residues 151-211) and an acceptor dye attached to either the N-lobe, the C-
lobe or the inter-lobe linker of cardiac troponin C. We performed ensemble
FRET measurements of the regulated actin filaments by measuring the time-
resolved fluorescence of the donor dye. For donor dyes located within the
intrinsically disordered switch II region of troponin I (residues 189-211),
FRET efficiency increased after saturation with Ca2þ and increased further
when the filaments were additionally saturated rigor myosin sub-fragment
1 (S1). Next, we used single-pair FRET to recover the subpopulations respon-
sible for the different FRET efficiencies. Sparsely donor-labeled regulated
actin filaments were reconstituted using a 1:20 mixture of troponin labeled
with both donor and acceptor dyes to troponin labeled with only acceptor
dye. FCS measurements of sparsely-labeled regulated actin filaments (500
nM in troponin) confirmed that there was on average less than 1 dye-pair
in the confocal volume at any given time. PIE-FRET experiments revealed
two subpopulations of troponin: inactive (low FRET efficiency) and active(high FRET efficiency). In Mg2þ-saturated filaments, greater than 95% of
troponin are inactive. In Ca2þ-saturated filaments, approximately 40% of
troponin are active. In Ca2þ-saturated and rigor S1-saturated filaments,
greater than 80% of troponin are active. We conclude that (1) Ca2þ alone
can cause Tn to activate, but the probability is modest that troponin will
be active; (2) rigor S1 increases the probability that troponin will remain
active.
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The cardiomyocyte t-tubule network is malleable; t-tubules develop
after birth and are disrupted during diseases such as heart failure (HF). In
failing cells, loss of the primarily transverse orientation of tubules is accom-
panied by growth of longitudinal t-tubules (LTTs), which we have shown
are compensatory. We presently hypothesized that bridging integrator 1
(BIN1), a membrane tubulating protein, triggers t-tubule growth during
both development and disease. Confocal microscopy and di-8-ANEPPS
staining revealed cardiomyocytes isolated from 10 day-old mice predomi-
nantly contained LTTs, whereas the mature transverse network began devel-
oping 10-15 days following birth. Additionally, we observed that cardiac
BIN1 protein levels in mice were highest during periods of t-tubule bio-
genesis, suggesting that BIN1 may be involved during early stages of devel-
opment. In rats examined 6 weeks following myocardial infarction,
appearance of LTTs was accompanied by a 2-fold increase in BIN1 tran-
script levels, despite marked loss of transverse elements. Immunostaining
of failing cardiomyocytes fixed in 4% paraformaldehyde confirmed the pres-
ence of BIN1 in newly formed LTTs. To directly examine whether BIN1
upregulation could underlie the observed appearance of LTTs in developing
and diseased cardiomyocytes, we expressed BIN1 in cultured cardiomyo-
cytes lacking t-tubules (HL-1 cells). Following transfection with exogenous
BIN1, a dense network of BIN1-positive sarcolemmal membrane invagina-
tions was formed in HL-1 cells as early as 12 hours after transfection.
Importantly, these tubules were chaotically organized and resembled the
LTTs grown prior to t-tubule maturation. Labeling of intracellular Ca2þ
with fluo-4 revealed that these tubules have t-tubule-like functionality, as
Ca2þ release events occurred adjacent to BIN1-positive tubules. We propose
that BIN1 initiates LTT growth during development and disease, and that
upregulation of BIN1 in the diseased heart may represent a return to an
immature gene program.
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Phospholamban (PLB) is a small integral membrane phosphoprotein that
inhibits the activity of the sarcoplasmic reticulum Ca-ATPase (SERCA)
by reducing its affinity for Ca. Several groups have shown that site-
specific chemical cross-linking of PLB to SERCA is abolished by elevated
Ca, suggesting the complex is dissociated by Ca-binding. However we and
others have previously observed that Ca does not abolish fluorescence reso-
nance energy transfer (FRET) from SERCA to PLB, suggesting that PLB
remains bound in high Ca. One possible explanation for the apparently con-
flicting results is that SERCA transition from E2 (Ca-free) to E1 (Ca-
bound) results in translocation of PLB from the canonical binding site to
a novel site. This translocation could diminish site-specific cross-linking
without abolishing FRET. In support of this hypothesis, preliminary
computational docking experiments suggest a possible secondary PLB
binding site on SERCA on the outside of helix M9. This site is analogous
to the FXYD protein binding site determined for the related P-type ATPase,
the Na/K-ATPase. To investigate PLB-SERCA binding to the putative
novel site, we labeled PLB with a photoactivatable cross-linker, benzophe-
none-4-maleimide and quantified cross-linking with SDS-PAGE and immu-
noblotting. We observed a high molecular weight species reactive to PLB
